Log in

Hill-Rom Stock Forecast, Price & News

+0.04 (+0.05 %)
(As of 09/23/2020 12:00 AM ET)
Today's Range
Now: $82.44
50-Day Range
MA: $91.49
52-Week Range
Now: $82.44
Volume794,091 shs
Average Volume662,410 shs
Market Capitalization$5.49 billion
P/E Ratio26.59
Dividend Yield1.07%
Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, and Monarch systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; and operating room surgical safety and accessory products, which comprise scalpels and blades, light handle systems, skin markers, and other disposable products. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.
Read More
Hill-Rom logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.06 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment



Sales & Book Value

Annual Sales$2.91 billion
Cash Flow$7.95 per share
Book Value$23.55 per share


Net Income$152.20 million


Market Cap$5.49 billion
Next Earnings Date11/6/2020 (Estimated)
+0.04 (+0.05 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HRC News and Ratings via Email

Sign-up to receive the latest news and ratings for HRC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Hill-Rom (NYSE:HRC) Frequently Asked Questions

How has Hill-Rom's stock price been impacted by COVID-19?

Hill-Rom's stock was trading at $89.15 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HRC stock has decreased by 7.5% and is now trading at $82.44.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Hill-Rom?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Hill-Rom

When is Hill-Rom's next earnings date?

Hill-Rom is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for Hill-Rom

How were Hill-Rom's earnings last quarter?

Hill-Rom Holdings, Inc. (NYSE:HRC) posted its quarterly earnings results on Friday, July, 31st. The medical technology company reported $1.95 earnings per share for the quarter, beating analysts' consensus estimates of $1.46 by $0.49. The medical technology company had revenue of $767.50 million for the quarter, compared to analyst estimates of $749.39 million. Hill-Rom had a return on equity of 25.48% and a net margin of 7.05%. The company's revenue for the quarter was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.23 EPS.
View Hill-Rom's earnings history

How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?

Hill-Rom announced a quarterly dividend on Wednesday, July 15th. Stockholders of record on Friday, September 18th will be given a dividend of $0.22 per share on Wednesday, September 30th. This represents a $0.88 annualized dividend and a yield of 1.07%. The ex-dividend date is Thursday, September 17th.
View Hill-Rom's dividend history

What guidance has Hill-Rom issued on next quarter's earnings?

Hill-Rom issued an update on its FY 2020 Pre-Market earnings guidance on Friday, July, 31st. The company provided EPS guidance of 5.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.54.

What price target have analysts set for HRC?

7 Wall Street analysts have issued twelve-month price targets for Hill-Rom's shares. Their forecasts range from $110.00 to $138.00. On average, they anticipate Hill-Rom's share price to reach $122.43 in the next twelve months. This suggests a possible upside of 48.5% from the stock's current price.
View analysts' price targets for Hill-Rom

Are investors shorting Hill-Rom?

Hill-Rom saw a increase in short interest in August. As of August 14th, there was short interest totaling 1,330,000 shares, an increase of 12.7% from the July 30th total of 1,180,000 shares. Based on an average trading volume of 676,000 shares, the short-interest ratio is currently 2.0 days. Currently, 2.0% of the company's shares are short sold.
View Hill-Rom's Short Interest

Who are some of Hill-Rom's key competitors?

What other stocks do shareholders of Hill-Rom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hill-Rom investors own include Steel Dynamics (STLD), Walt Disney (DIS), NVIDIA (NVDA), Paypal (PYPL), Square (SQ), salesforce.com (CRM), Micron Technology (MU), CVS Health (CVS), Mastercard (MA) and Trade Desk (TTD).

Who are Hill-Rom's key executives?

Hill-Rom's management team includes the following people:
  • Mr. John P. Groetelaars, Pres, CEO & Director (Age 52)
  • Mr. Carlos Alonso-Marum, Sr. VP & Pres of International (Age 60)
  • Mr. Paul Johnson, Sr. VP & Pres of Patient Support Systems (Age 54)
  • Mr. Steven J. Strobel, Sr. Advisor (Age 61)
  • Ms. Barbara W. Bodem, Sr. VP & CFO (Age 51)

What is Hill-Rom's stock symbol?

Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."

Who are Hill-Rom's major shareholders?

Hill-Rom's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.43%), Victory Capital Management Inc. (3.22%), Bank of America Corp DE (1.87%), FMR LLC (1.41%), Neuberger Berman Group LLC (1.40%) and Bank of New York Mellon Corp (1.25%). Company insiders that own Hill-Rom stock include Amy M Dodrill, Andreas G Frank, Deborah Rasin, Mary Kay Ladone and Paul Sherwood Johnson.
View institutional ownership trends for Hill-Rom

Which institutional investors are selling Hill-Rom stock?

HRC stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, FMR LLC, Bank of New York Mellon Corp, Jennison Associates LLC, Charles Schwab Investment Management Inc., Vanguard Group Inc., Wedge Capital Management L L P NC, and Fisher Asset Management LLC. Company insiders that have sold Hill-Rom company stock in the last year include Amy M Dodrill, Andreas G Frank, Deborah Rasin, Mary Kay Ladone, and Paul Sherwood Johnson.
View insider buying and selling activity for Hill-Rom

Which institutional investors are buying Hill-Rom stock?

HRC stock was acquired by a variety of institutional investors in the last quarter, including Holocene Advisors LP, Victory Capital Management Inc., Bank of America Corp DE, LSV Asset Management, Silvercrest Asset Management Group LLC, Candriam Luxembourg S.C.A., Bellevue Group AG, and AQR Capital Management LLC.
View insider buying and selling activity for Hill-Rom

How do I buy shares of Hill-Rom?

Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Hill-Rom's stock price today?

One share of HRC stock can currently be purchased for approximately $82.44.

How big of a company is Hill-Rom?

Hill-Rom has a market capitalization of $5.49 billion and generates $2.91 billion in revenue each year. The medical technology company earns $152.20 million in net income (profit) each year or $5.08 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe.

What is Hill-Rom's official website?

The official website for Hill-Rom is www.hill-rom.com.

How can I contact Hill-Rom?

Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.